New Drug Discovery for Alzheimer's Disease: Challenges and Hopes
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Advancing Alzheimer's Therapy: Computational strategies and treatment innovations.
Paul J, Malik A, Azmal M, Gulzar T, Afghan M, Talukder O IBRO Neurosci Rep. 2025; 18:270-282.
PMID: 39995567 PMC: 11849200. DOI: 10.1016/j.ibneur.2025.02.002.
Kosagisharaf J, Hegde M J Alzheimers Dis. 2023; 94(s1):S3-S7.
PMID: 37393511 PMC: 10473067. DOI: 10.3233/JAD-230622.
References
1.
Venugopal C, Demos C, Rao K, Pappolla M, Sambamurti K
. Beta-secretase: structure, function, and evolution. CNS Neurol Disord Drug Targets. 2008; 7(3):278-94.
PMC: 2921875.
DOI: 10.2174/187152708784936626.
View
2.
Selkoe D
. Biochemistry of altered brain proteins in Alzheimer's disease. Annu Rev Neurosci. 1989; 12:463-90.
DOI: 10.1146/annurev.ne.12.030189.002335.
View
3.
Whitehead K, Langer R, Anderson D
. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009; 8(2):129-38.
PMC: 7097568.
DOI: 10.1038/nrd2742.
View
4.
Gonzalez-Alegre P
. Therapeutic RNA interference for neurodegenerative diseases: From promise to progress. Pharmacol Ther. 2007; 114(1):34-55.
DOI: 10.1016/j.pharmthera.2007.01.003.
View
5.
Kawahara Y
. [MicroRNAs in neurobiology]. Brain Nerve. 2008; 60(12):1437-44.
View